| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 15 | 0 | 0 | 15 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 27 | 0 | 0 | 27 |
| USP1 protein, partial | 37 | 0 | 0 | 37 |
| TDP1 protein | 59 | 0 | 0 | 59 |
| vitamin D3 receptor isoform VDRA | 27 | 0 | 0 | 27 |
| importin subunit beta-1 isoform 1 | 8 | 0 | 0 | 8 |
| flap endonuclease 1 | 24 | 0 | 0 | 24 |
| serine/threonine-protein kinase PLK1 | 10 | 0 | 0 | 10 |
| snurportin-1 | 8 | 0 | 0 | 8 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 12 | 0 | 0 | 12 |
| GTP-binding nuclear protein Ran isoform 1 | 5 | 0 | 0 | 5 |
| DNA polymerase eta isoform 1 | 9 | 0 | 0 | 9 |
| DNA polymerase iota isoform a (long) | 24 | 0 | 0 | 24 |
| urokinase-type plasminogen activator precursor | 14 | 0 | 0 | 14 |
| plasminogen precursor | 14 | 0 | 0 | 14 |
| urokinase plasminogen activator surface receptor precursor | 14 | 0 | 0 | 14 |
| geminin | 56 | 0 | 0 | 56 |
| DNA polymerase kappa isoform 1 | 27 | 0 | 0 | 27 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 3 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Transthyretin | 0 | 4 | 3 | 8 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein, adipocyte | 0 | 3 | 1 | 4 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 1 | 2 |
| Cyclin-dependent kinase 2 | 0 | 1 | 2 | 3 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 11 | 0 | 0 | 11 |
| Fatty acid-binding protein 5 | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 6 | 0 | 6 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 32 | 0 | 0 | 32 |
| lamin isoform A-delta10 | 44 | 0 | 0 | 44 |
| hypoxia-inducible factor 1 alpha subunit | 30 | 0 | 0 | 30 |
| RAR-related orphan receptor gamma | 60 | 0 | 0 | 60 |
| GLI family zinc finger 3 | 60 | 0 | 0 | 60 |
| AR protein | 81 | 0 | 0 | 81 |
| aldehyde dehydrogenase 1 family, member A1 | 49 | 0 | 0 | 49 |
| retinoic acid nuclear receptor alpha variant 1 | 70 | 0 | 0 | 70 |
| retinoid X nuclear receptor alpha | 59 | 0 | 0 | 59 |
| estrogen nuclear receptor alpha | 86 | 0 | 0 | 86 |
| peroxisome proliferator-activated receptor delta | 42 | 0 | 0 | 42 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 46 | 0 | 0 | 46 |
| activating transcription factor 6 | 29 | 0 | 0 | 29 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 39 | 0 | 0 | 39 |
| Histone H2A.x | 32 | 0 | 0 | 32 |
| thyroid hormone receptor beta isoform a | 35 | 0 | 0 | 35 |
| heat shock protein beta-1 | 30 | 0 | 0 | 30 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 64 | 0 | 0 | 64 |
| Voltage-dependent calcium channel gamma-2 subunit | 36 | 0 | 0 | 36 |
| Glutamate receptor 2 | 37 | 0 | 0 | 37 |
| Protein skinhead-1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 6 | 1 | 7 |
| Tyrosine-protein kinase Fyn | 0 | 5 | 1 | 6 |
| Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 22 | 0 | 0 | 22 |
| Microtubule-associated protein tau | 30 | 0 | 0 | 30 |
| Smad3 | 14 | 0 | 0 | 14 |
| alpha-galactosidase | 8 | 0 | 0 | 8 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 23 | 0 | 0 | 23 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 13 | 0 | 13 |
| thyroid stimulating hormone receptor | 34 | 0 | 0 | 34 |
| peroxisome proliferator activated receptor gamma | 45 | 0 | 0 | 45 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 4 | 5 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 28 | 0 | 0 | 28 |
| Carbonic anhydrase 1 | 0 | 11 | 0 | 16 |
| Carbonic anhydrase 2 | 0 | 12 | 1 | 19 |
| Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 1 | 9 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 22 | 0 | 0 | 22 |
| Luciferase | 36 | 0 | 0 | 36 |
| glp-1 receptor, partial | 18 | 0 | 0 | 18 |
| ATAD5 protein, partial | 16 | 0 | 0 | 16 |
| Fumarate hydratase | 11 | 0 | 0 | 11 |
| caspase 7, apoptosis-related cysteine protease | 13 | 0 | 0 | 13 |
| nuclear receptor subfamily 1, group I, member 3 | 53 | 0 | 0 | 53 |
| progesterone receptor | 42 | 0 | 0 | 42 |
| glucocorticoid receptor [Homo sapiens] | 53 | 0 | 0 | 53 |
| estrogen-related nuclear receptor alpha | 73 | 0 | 0 | 73 |
| farnesoid X nuclear receptor | 41 | 0 | 0 | 41 |
| pregnane X nuclear receptor | 63 | 0 | 0 | 63 |
| polyprotein | 11 | 0 | 0 | 11 |
| 67.9K protein | 18 | 0 | 0 | 18 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 44 | 0 | 0 | 44 |
| caspase-3 | 13 | 0 | 0 | 13 |
| IDH1 | 19 | 0 | 0 | 19 |
| euchromatic histone-lysine N-methyltransferase 2 | 51 | 0 | 0 | 51 |
| aryl hydrocarbon receptor | 40 | 0 | 0 | 40 |
| nuclear receptor subfamily 1, group I, member 2 | 9 | 0 | 0 | 9 |
| cellular tumor antigen p53 isoform a | 15 | 0 | 0 | 15 |
| chromobox protein homolog 1 | 31 | 0 | 0 | 31 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 21 | 0 | 0 | 21 |
| transcriptional regulator ERG isoform 3 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 59 | 0 | 0 | 59 |
| histone deacetylase 9 isoform 3 | 11 | 0 | 0 | 11 |
| mitogen-activated protein kinase 1 | 22 | 0 | 0 | 22 |
| Vif | 0 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 29 | 0 | 0 | 29 |
| survival motor neuron protein isoform d | 23 | 0 | 0 | 23 |
| muscleblind-like protein 1 isoform 1 | 14 | 0 | 0 | 14 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 8 | 0 | 0 | 8 |
| ATP-binding cassette sub-family C member 3 | 0 | 22 | 0 | 22 |
| Multidrug resistance-associated protein 4 | 0 | 23 | 0 | 24 |
| Bile salt export pump | 0 | 34 | 0 | 35 |
| Interferon beta | 37 | 0 | 0 | 37 |
| Cellular tumor antigen p53 | 56 | 0 | 0 | 56 |
| Integrin beta-3 | 9 | 0 | 0 | 9 |
| Integrin alpha-IIb | 9 | 0 | 0 | 9 |
| Methionine aminopeptidase | 0 | 4 | 0 | 4 |
| Fatty-acid amide hydrolase 1 | 0 | 5 | 0 | 5 |
| Inositol monophosphatase 1 | 11 | 0 | 0 | 11 |
| Canalicular multispecific organic anion transporter 1 | 0 | 22 | 0 | 22 |
| ATPase family AAA domain-containing protein 5 | 30 | 0 | 0 | 30 |
| Ataxin-2 | 33 | 0 | 0 | 33 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 4 | 0 | 4 |
| regulator of G-protein signaling 4 | 15 | 0 | 0 | 15 |
| EWS/FLI fusion protein | 20 | 0 | 0 | 20 |
| thyrotropin-releasing hormone receptor | 7 | 0 | 0 | 7 |
| Muscarinic acetylcholine receptor M2 | 0 | 11 | 2 | 16 |
| Muscarinic acetylcholine receptor M4 | 0 | 11 | 2 | 15 |
| Muscarinic acetylcholine receptor M1 | 0 | 9 | 1 | 13 |
| Muscarinic acetylcholine receptor M3 | 0 | 9 | 1 | 13 |
| Muscarinic acetylcholine receptor M4 | 0 | 9 | 1 | 13 |
| Muscarinic acetylcholine receptor M5 | 0 | 9 | 1 | 13 |
| Muscarinic acetylcholine receptor M5 | 0 | 11 | 2 | 15 |
| Neuronal acetylcholine receptor subunit alpha-4 | 4 | 1 | 0 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 9 | 1 | 14 |
| Muscarinic acetylcholine receptor M1 | 0 | 11 | 2 | 16 |
| Neuronal acetylcholine receptor subunit beta-2 | 4 | 1 | 0 | 5 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 11 | 2 | 15 |
| Muscarinic acetylcholine receptor | 0 | 2 | 1 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| phosphopantetheinyl transferase | 29 | 0 | 0 | 29 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| GLS protein | 19 | 0 | 0 | 19 |
| cytochrome P450 2C19 precursor | 11 | 0 | 0 | 11 |
| muscarinic acetylcholine receptor M1 | 8 | 0 | 0 | 8 |
| lethal factor (plasmid) | 23 | 0 | 0 | 23 |
| Cytochrome P450 3A4 | 0 | 8 | 1 | 10 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 2 | 0 | 3 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 1 | 1 | 4 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 16 | 0 | 0 | 16 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 36 | 0 | 0 | 36 |
| G | 24 | 0 | 0 | 24 |
| HLA class I histocompatibility antigen, B alpha chain | 24 | 0 | 0 | 24 |
| Inositol hexakisphosphate kinase 1 | 24 | 0 | 0 | 24 |
| cytochrome P450 2C9, partial | 24 | 0 | 0 | 24 |
| nonstructural protein 1 | 15 | 0 | 0 | 15 |
| TAR DNA-binding protein 43 | 15 | 0 | 0 | 15 |
| Dihydroorotate dehydrogenase | 0 | 3 | 0 | 3 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 27 | 0 | 0 | 27 |
| thioredoxin glutathione reductase | 12 | 0 | 0 | 12 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 6 | 0 | 0 | 6 |
| Polyphenol oxidase 2 | 0 | 6 | 0 | 10 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 1 | 3 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 4 | 0 | 4 |
| Alpha-2B adrenergic receptor | 0 | 11 | 1 | 12 |
| Spike glycoprotein | 24 | 3 | 5 | 32 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| SMAD family member 2 | 21 | 0 | 0 | 21 |
| SMAD family member 3 | 21 | 0 | 0 | 21 |
| estrogen receptor 2 (ER beta) | 37 | 0 | 0 | 37 |
| cytochrome P450 2D6 | 26 | 0 | 0 | 26 |
| glucocerebrosidase | 7 | 0 | 0 | 7 |
| bromodomain adjacent to zinc finger domain 2B | 23 | 0 | 0 | 23 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 29 | 0 | 0 | 29 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 28 | 0 | 0 | 28 |
| Caspase-7 | 9 | 0 | 0 | 9 |
| Spike glycoprotein | 0 | 3 | 5 | 8 |
| Replicase polyprotein 1ab | 0 | 3 | 5 | 8 |
| cytochrome P450 2D6 isoform 1 | 9 | 0 | 0 | 9 |
| lysosomal alpha-glucosidase preproprotein | 10 | 0 | 0 | 10 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 19 | 0 | 0 | 19 |
| caspase-3 | 9 | 0 | 0 | 9 |
| huntingtin isoform 2 | 14 | 0 | 0 | 14 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 11 | 0 | 0 | 11 |
| nuclear receptor ROR-gamma isoform 1 | 29 | 0 | 0 | 29 |
| cytochrome P450 3A4 isoform 1 | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit pi | 39 | 0 | 0 | 39 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 12 | 0 | 0 | 12 |
| Transmembrane protease serine 2 | 0 | 3 | 5 | 8 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 12 | 0 | 12 |
| Polycomb protein EED | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 8 | 0 | 8 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 5 | 0 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Procathepsin L | 0 | 3 | 5 | 8 |
| Aldo-keto reductase family 1 member B1 | 0 | 11 | 0 | 11 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 5 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 13 | 0 | 13 |
| Replicase polyprotein 1a | 0 | 5 | 5 | 10 |
| Replicase polyprotein 1ab | 0 | 3 | 5 | 8 |
| Replicase polyprotein 1ab | 0 | 6 | 5 | 11 |
| Adenosine receptor A3 | 0 | 15 | 0 | 15 |
| Replicase polyprotein 1ab | 0 | 7 | 6 | 13 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 39 | 0 | 0 | 39 |
| Alpha-1B adrenergic receptor | 0 | 16 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit delta | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 39 | 0 | 0 | 39 |
| Alpha-2C adrenergic receptor | 0 | 15 | 0 | 15 |
| 5-hydroxytryptamine receptor 1A | 0 | 7 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 39 | 0 | 0 | 39 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 8 | 0 | 8 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 4 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 39 | 0 | 0 | 39 |
| Sodium-dependent noradrenaline transporter | 0 | 10 | 3 | 13 |
| Histamine H2 receptor | 0 | 9 | 2 | 11 |
| Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
| Substance-P receptor | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 7 | 0 | 7 |
| 5-hydroxytryptamine receptor 2C | 0 | 12 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 39 | 0 | 0 | 39 |
| 5-hydroxytryptamine receptor 1B | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 39 | 0 | 0 | 39 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 7 | 2 | 9 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| D(3) dopamine receptor | 0 | 8 | 0 | 8 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 10 | 0 | 10 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 16 | 0 | 16 |
| Histamine H2 receptor | 16 | 2 | 2 | 21 |
| 5-hydroxytryptamine receptor 6 | 0 | 6 | 0 | 6 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 39 | 0 | 0 | 39 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 39 | 0 | 0 | 39 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 5 | 0 | 0 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 8 | 0 | 8 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 1 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 39 | 0 | 0 | 39 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 7 | 0 | 7 |
| Angiotensin-converting enzyme 2 | 0 | 3 | 5 | 8 |
| Gamma-aminobutyric acid receptor subunit epsilon | 39 | 0 | 0 | 39 |
| Histamine H4 receptor | 0 | 4 | 2 | 6 |
| Heparanase | 0 | 0 | 1 | 1 |
| pregnane X receptor | 17 | 0 | 0 | 17 |
| Nuclear receptor ROR-gamma | 25 | 1 | 1 | 27 |
| Chain A, 2-oxoglutarate Oxygenase | 25 | 0 | 0 | 25 |
| cystic fibrosis transmembrane conductance regulator | 0 | 2 | 0 | 2 |
| DNA polymerase beta | 15 | 0 | 0 | 15 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 9 | 0 | 10 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 2 |
| Nrf2 | 2 | 0 | 0 | 2 |
| BRCA1 | 2 | 0 | 0 | 2 |
| SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, isoform CRA_a | 0 | 0 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 isoform b | 0 | 1 | 0 | 1 |
| polyadenylate-binding protein 1 | 0 | 2 | 0 | 2 |
| caspase-1 isoform alpha precursor | 8 | 0 | 0 | 8 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
| Caspase-7 | 7 | 0 | 0 | 7 |
| Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
| Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 2 |
| GTPase KRas | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
| Glutaminyl-peptide cyclotransferase | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 3 | 0 | 3 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 15 | 0 | 0 | 15 |
| Chain A, HADH2 protein | 23 | 0 | 0 | 23 |
| Chain B, HADH2 protein | 23 | 0 | 0 | 23 |
| Chain A, Cruzipain | 12 | 0 | 0 | 12 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 6 | 0 | 9 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 6 | 0 | 10 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 13 | 0 | 0 | 13 |
| interleukin 8 | 14 | 0 | 0 | 14 |
| calpain II, partial | 0 | 2 | 0 | 2 |
| 15-lipoxygenase, partial | 18 | 0 | 0 | 18 |
| Mcl-1 | 0 | 4 | 0 | 4 |
| Estrogen receptor 1 | 0 | 3 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 20 | 0 | 0 | 20 |
| envelope glycoprotein | 0 | 3 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 19 | 0 | 0 | 19 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 10 | 0 | 0 | 10 |
| estrogen receptor beta isoform 1 | 0 | 3 | 0 | 3 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 7 | 0 | 0 | 7 |
| histone acetyltransferase KAT2A isoform 1 | 28 | 0 | 0 | 28 |
| Solute carrier family 22 member 2 | 0 | 4 | 0 | 6 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 6 | 6 |
| Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
| 60 kDa chaperonin | 0 | 6 | 0 | 6 |
| 60 kDa heat shock protein, mitochondrial | 0 | 8 | 0 | 8 |
| Thromboxane-A synthase | 0 | 3 | 0 | 3 |
| Mitogen-activated protein kinase 1 | 0 | 6 | 0 | 6 |
| Adenosine receptor A2a | 0 | 8 | 1 | 10 |
| 10 kDa heat shock protein, mitochondrial | 0 | 8 | 0 | 8 |
| Pup--protein ligase | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 4 | 0 | 0 | 4 |
| Thiosulfate sulfurtransferase | 0 | 8 | 0 | 8 |
| 60 kDa chaperonin | 0 | 8 | 0 | 8 |
| 10 kDa chaperonin | 0 | 8 | 0 | 8 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| M1-family alanyl aminopeptidase | 0 | 2 | 0 | 2 |
| large T antigen | 0 | 4 | 0 | 4 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 2 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 2 | 1 | 5 |
| B1 bradykinin receptor | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 3 | 3 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 6 | 0 | 0 | 6 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 4 | 0 | 4 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 2 | 4 | 0 | 10 |
| Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 1 | 4 |
| Adenosine receptor A2a | 0 | 3 | 0 | 8 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Guanine deaminase | 0 | 2 | 0 | 2 |
| Chain A, Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | 0 | 0 | 1 | 1 |
| kallikrein-5 preproprotein | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2E1 | 0 | 1 | 0 | 1 |
| luciferase | 3 | 0 | 0 | 3 |
| eyes absent homolog 2 isoform a | 3 | 0 | 0 | 3 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 10 | 4 | 0 | 14 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 8 | 0 | 12 |
| Carbonic anhydrase | 0 | 6 | 0 | 10 |
| Carbonic anhydrase 15 | 0 | 5 | 0 | 9 |
| PPM1D protein | 13 | 0 | 0 | 13 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 2 | 0 | 2 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Riboflavin-binding protein | 0 | 1 | 2 | 3 |
| Major prion protein | 0 | 0 | 3 | 3 |
| Amyloid-beta precursor protein | 1 | 4 | 0 | 5 |
| Histidine-rich protein PFHRP-II | 0 | 2 | 0 | 3 |
| Spike glycoprotein | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
| DNA ligase 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 2 | 2 |
| Beta-secretase 1 | 0 | 4 | 0 | 4 |
| Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| DNA ligase A | 0 | 1 | 0 | 1 |
| Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| PINK1 | 8 | 0 | 0 | 8 |
| Parkin | 10 | 0 | 0 | 10 |
| serine-protein kinase ATM isoform a | 4 | 0 | 0 | 4 |
| prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 10 | 0 | 0 | 10 |
| ORF73 | 0 | 0 | 1 | 1 |
| arylsulfatase A | 9 | 0 | 0 | 9 |
| M-phase phosphoprotein 8 | 13 | 0 | 0 | 13 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 3 | 1 | 4 |
| Cytochrome P450 2C9 | 0 | 6 | 1 | 7 |
| Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 1 | 4 | 5 |
| Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
| Solute carrier family 22 member 8 | 0 | 4 | 0 | 5 |
| Solute carrier family 22 member 11 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 5 | 0 | 6 |
| Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 3 | 0 | 3 |
| shiga toxin 1 variant A subunit | 1 | 0 | 0 | 1 |
| shiga toxin 1 B subunit | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 9 | 0 | 0 | 9 |
| Cell division protein FtsZ | 0 | 1 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| SUMO-1 | 0 | 2 | 0 | 2 |
| TSHR protein | 6 | 0 | 0 | 6 |
| hexokinase | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 5 | 0 | 0 | 5 |
| streptokinase A precursor | 0 | 0 | 4 | 4 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Long-chain-fatty-acid--AMP ligase FadD32 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 9 | 0 | 0 | 9 |
| Sporulation initiation phosphotransferase F | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Sporulation kinase A | 0 | 1 | 0 | 1 |
| Chitinase | 0 | 4 | 0 | 4 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 2 | 0 | 3 |
| GALC protein | 6 | 0 | 0 | 6 |
| Thrombopoietin | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 6 | 0 | 0 | 6 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
| Mineralocorticoid receptor | 0 | 2 | 2 | 4 |
| Androgen receptor | 0 | 8 | 0 | 8 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 3 | 0 | 4 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 2 | 0 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | 9 | 0 | 0 | 9 |
| ras-related protein Rab-9A | 7 | 0 | 0 | 7 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 4 | 0 | 4 |
| Solute carrier family 2, facilitated glucose transporter member 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
| Chain A, Odorant binding protein | 0 | 0 | 1 | 1 |
| Chain B, Odorant binding protein | 0 | 0 | 1 | 1 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 6 |
| Endoplasmic reticulum chaperone BiP | 0 | 3 | 0 | 3 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 3 |
| heat shock protein 90, putative | 0 | 0 | 0 | 5 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 2 | 0 | 2 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 2 | 0 | 2 |
| Histone deacetylase 3 | 0 | 3 | 0 | 3 |
| Poly [ADP-ribose] polymerase tankyrase-1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 5 | 0 | 5 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 3 | 0 | 3 |
| Hydroxycarboxylic acid receptor 2 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| Histone deacetylase 2 | 0 | 3 | 0 | 3 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
| NS5 | 0 | 0 | 1 | 1 |
| Glucose transporter | 0 | 1 | 0 | 1 |
| Serine hydrolase RBBP9 | 0 | 1 | 0 | 1 |
| Hexose transporter 1 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 2 |
| Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 2 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | 4 | 0 | 0 | 4 |
| hypothetical protein, conserved | 4 | 0 | 0 | 4 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| cytochrome P450 2C9 precursor | 8 | 0 | 0 | 8 |
| D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
| Cocaine esterase | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 6 | 0 | 7 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 3 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
| Neuropeptide FF receptor 2 | 0 | 1 | 1 | 2 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 2 | 0 | 4 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 3 |
| Fucose-binding lectin PA-IIL | 0 | 2 | 0 | 2 |
| CD209 antigen | 0 | 3 | 0 | 3 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 7 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 7 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 7 |
| Large neutral amino acids transporter small subunit 1 | 0 | 5 | 0 | 5 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 7 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 7 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 7 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Glutamine synthetase | 0 | 1 | 0 | 1 |
| Cytochrome P450 71B1 | 0 | 1 | 0 | 2 |
| Glutamine synthetase | 0 | 1 | 0 | 1 |
| 2-dehydro-3-deoxyphosphooctonate aldolase | 0 | 1 | 0 | 1 |
| DNA polymerase III, partial | 2 | 0 | 0 | 2 |
| galactokinase | 4 | 0 | 0 | 4 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 3 | 0 | 3 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 3 | 0 | 3 |
| 4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | 2 | 0 | 0 | 2 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 2 | 1 | 3 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| DNA-3-methyladenine glycosylase | 0 | 1 | 0 | 1 |
| Caspase-1 | 3 | 2 | 0 | 5 |
| DNA repair protein RAD52 homolog | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| Type 1 InsP3 receptor isoform S2 | 3 | 0 | 0 | 3 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 2 | 1 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 1 | 3 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
| Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 1 | 0 | 0 | 1 |
| phosphoglycerate kinase | 5 | 0 | 0 | 5 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 3 | 0 | 0 | 3 |
| Valosin-containing protein | 0 | 3 | 0 | 3 |
| pyruvate kinase | 6 | 0 | 0 | 6 |
| pyruvate kinase PKM isoform a | 3 | 0 | 0 | 3 |
| Endothelin receptor type B | 3 | 0 | 0 | 3 |
| Endothelin-1 receptor | 3 | 0 | 0 | 3 |
| PAX8 | 0 | 0 | 0 | 2 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| heat shock 70kDa protein 1A | 0 | 1 | 0 | 1 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| neuropeptide Y receptor type 1 | 0 | 0 | 1 | 1 |
| neuropeptide Y receptor type 2 | 0 | 0 | 1 | 1 |
| small ubiquitin-related modifier 2 isoform b precursor | 0 | 1 | 0 | 1 |
| enteropeptidase precursor | 1 | 0 | 0 | 1 |
| fatty acid synthase | 0 | 1 | 0 | 1 |
| heat shock cognate 71 kDa protein isoform 1 | 0 | 1 | 0 | 1 |
| Vpr | 5 | 0 | 0 | 5 |
| replicative DNA helicase | 0 | 0 | 0 | 2 |
| recombinase A | 0 | 0 | 2 | 2 |
| exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 3 | 3 |
| heat shock cognate 71 kDa protein isoform 2 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 6 | 1 | 7 |
| Estrogen receptor | 0 | 0 | 2 | 2 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 5 | 0 | 5 |
| Mitogen-activated protein kinase 3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 4 | 1 | 5 |
| Estrogen receptor beta | 0 | 0 | 2 | 2 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 3 | 3 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| BZLF2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 7 | 0 | 0 | 7 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 6 |
| Plasma kallikrein | 0 | 0 | 0 | 4 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 6 |
| Carbonic anhydrase 6 | 0 | 5 | 0 | 9 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 5 | 0 | 9 |
| Carbonic anhydrase 7 | 0 | 4 | 0 | 8 |
| Carbonic anhydrase | 0 | 0 | 0 | 5 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 6 | 1 | 11 |
| Carbonic anhydrase | 0 | 1 | 0 | 6 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 4 |
| Carbonic anhydrase | 0 | 2 | 0 | 7 |
| Carbonic anhydrase | 0 | 1 | 0 | 6 |
| Carbonic anhydrase | 0 | 0 | 0 | 5 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 4 | 0 | 7 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 6 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 4 | 0 | 8 |
| Histamine H3 receptor | 0 | 1 | 2 | 3 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| citrate synthase 2, partial | 0 | 0 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| LAP4 | 0 | 0 | 1 | 1 |
| MEP2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 3 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 2 | 1 | 3 |
| Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
| Free fatty acid receptor 1 | 0 | 0 | 2 | 2 |
| Free fatty acid receptor 4 | 0 | 0 | 2 | 2 |
| G-protein coupled receptor 84 | 0 | 1 | 1 | 2 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 3 | 0 | 3 |
| Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
| WRN | 3 | 0 | 0 | 3 |
| integrase, partial | 0 | 2 | 0 | 2 |
| lens epithelium-derived growth factor p75 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 3 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Trypsin | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 2 | 0 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| DNA-(apurinic or apyrimidinic site) endonuclease | 0 | 1 | 1 | 2 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Alpha-mannosidase 2C1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 3 | 0 | 3 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 3 | 0 | 3 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 2 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 3 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 2 | 1 | 3 |
| Cruzipain | 0 | 2 | 0 | 2 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain A, NAD-dependent deacetylase | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
| NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| NAD(+) hydrolase SARM1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
| pyruvate kinase PKM isoform b | 3 | 0 | 0 | 3 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 3 | 0 | 0 | 4 |
| Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
| Mast/stem cell growth factor receptor Kit | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 3 | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 8 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Angiopoietin-1 receptor | 0 | 1 | 0 | 1 |
| Anoctamin-1 | 0 | 2 | 0 | 2 |
| Pyruvate-flavodoxin oxidoreductase | 0 | 1 | 0 | 1 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| Exportin-1 | 0 | 1 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 2 | 2 |
| Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| RGS12 | 1 | 0 | 0 | 1 |
| metallo beta-lactamase | 0 | 1 | 0 | 1 |
| metallo-beta-lactamase IMP-1 | 0 | 1 | 0 | 1 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Endolysin | 0 | 0 | 2 | 2 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| NADPH oxidase 1 | 0 | 1 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 2 |
| rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 2 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
| Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
| Monocarboxylate transporter 4 | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 2 | 0 | 2 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 1 | 0 | 4 | 1 | 5 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 2 | 0 | 3 | 1 | 4 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 9B2 | 0 | 1 | 0 | 1 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Sodium/nucleoside cotransporter 1 | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 1 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 1 | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 2 | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 5 member 4 | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 0 | 1 |
| Complement C1s subcomponent | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 4 | 2 | 11 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Trypanothione reductase | 0 | 4 | 0 | 4 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 2 | 0 | 0 | 2 |
| core-binding factor subunit beta isoform 2 | 2 | 0 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| N | 0 | 1 | 0 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
| Major prion protein | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit alpha | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit omega | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta' | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
| Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
| Acidic phospholipase A2 2 | 0 | 1 | 0 | 1 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| MSRA protein | 0 | 1 | 0 | 1 |
| plectin 1 | 0 | 1 | 0 | 1 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| Tissue alpha-L-fucosidase | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 3 | 0 | 5 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
| Albumin | 0 | 1 | 2 | 3 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 3 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Stromelysin-1 | 0 | 1 | 1 | 2 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Laccase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Substance-K receptor | 0 | 1 | 1 | 2 |
| Neuromedin-K receptor | 0 | 1 | 1 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 0 | 1 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
| Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
| Sodium/bile acid cotransporter | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 0 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 2 |
| Ileal sodium/bile acid cotransporter | 0 | 0 | 0 | 1 |
| Ileal sodium/bile acid cotransporter | 0 | 1 | 0 | 2 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 2 |
| Ileal sodium/bile acid cotransporter | 0 | 0 | 0 | 1 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 14alpha-demethylase | 0 | 0 | 1 | 1 |
| Sterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| P53 | 1 | 0 | 0 | 1 |
| Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
| Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 4 | 6 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
| Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
| Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| hepatitis C virus polyprotein | 1 | 0 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
| Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| ClpP | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |